Pathogenic fusion detection in solid malignancies utilizing RNA-DNA based comprehensive genomic profiling (CGP) testing.
Brian Piening(Providence College), Carlo Bifulco(Providence Health & Services), Josiah T. Wagner(Unknown), Bela Bapat(Illumina (United States)), Mark Schmidt(Cancer Institute (WIA)), Stanley Piotrowski(Providence Portland Medical Center), Lauren Harold(Providence Portland Medical Center), Brock E. Schroeder(Illumina (United States)), Phillip G. Febbo(Veracyte (United States)), Thomas Ward(Providence Portland Medical Center), Ann Vita(Providence Portland Medical Center), Shu‐Ching Chang(Providence College), Roshanthi Weerasinghe(Providence College), Alexa K. Dowdell(Providence Portland Medical Center), Alisha Stein(Illumina (United States)), Ryan Meng(Providence Portland Medical Center)
Cited by 0
Related Papers
Gene expression correlates of clinical prostate cancer behavior
|Cancer Cell|2002|2.5k
The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight
|Science|2019|1.1k
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways
|Nature Medicine|2004|956
Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression
|Journal of Clinical Oncology|2008|917
Cancer classification using the Immunoscore: a worldwide task force
|Journal of Translational Medicine|2012|803